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Background: Studies have addressed the immunomodulatory effects of helminths and their protective
effects upon asthma. However, anti-Ascaris IgE has been reported to be associated with an increased risk
of asthma symptoms. We examined the association between serum levels of anti-Ascaris IgE and
bronchial hyper-responsiveness (BHR) in children living in rural Bangladesh.
Methods: Serum anti-Ascaris IgE level was measured and the BHR test done in 158 children aged 9 years
selected randomly from a general population of 1705 in the Matlab Health and Demographic Surveillance
Area of the International Centre for Diarrhoeal Disease Research, Bangladesh. We investigated wheezing
symptoms using a questionnaire from the International Study of Asthma and Allergies in Childhood. BHR
tests were successfully done on 152 children (108 ‘current wheezers’; 44 ‘never-wheezers’). We exam-
ined the association between anti-Ascaris IgE level and wheezing and BHR using multiple logistic
regression analyses.
Results: Of 108 current-wheezers, 59 were BHR-positive; of 44 never-wheezers, 32 were BHR-negative.
Mean anti-Ascaris IgE levels were signiﬁcantly higher (12.51 UA/ml; 95% conﬁdence interval (CI), 9.21
e17.00) in children with current wheezing with BHR-positive than in those of never-wheezers with BHR-
negative (3.89; 2.65e5.70; t test, p < 0.001). A BHR-positive test was independently associated with anti-
Ascaris IgE levels with an odds ratio (OR) ¼ 7.30 [95% CI, 2.28e23.33], p ¼ 0.001 when adjusted for total
IgE, anti-Dermatophagoides pteronyssinus IgE, pneumonia history, parental asthma, Trichuris infection,
forced expiratory volume in one second, eosinophilic leukocyte count, and sex.
Conclusions: Anti-Ascaris IgE level is associated with an increased risk of BHR among 9-year-old rural
Bangladeshi children.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).and Global Health, Graduate
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The speciﬁc features of bronchial asthma (BA) are chronic
inﬂammation and hyper-responsiveness of the airways. BA is one ofvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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the worldwide prevalence of BA since the 1970s has been docu-
mented, and certain environmental factors have been postulated to
contribute to this increase.3 Such ﬁndings provoked the hypothesis
that helminthic infections, which are common in rural and
‘developing’ areas, might protect against asthma and allergy.
The ‘hygiene hypothesis’, ﬁrst proposed by Strachan,4 accounts
for the increase in terms of the balance between T-helper 1 (Th1)
and Th2 immunity. However, the ‘modiﬁed hygiene hypothesis’
explains the inverse association by invoking the notion that a
downregulatory mechanism (now recognized as a T regulatory
(Treg) immune response) works in the presence of chronic infec-
tion. Speciﬁcally, the modiﬁed hygiene hypothesis suggests that T-
regulatory cytokines such as interleukin (IL)-10 and transforming
growth factor (TGF)-b are stimulated if there is a chronic infection
regardless of the type of T-helper cell, and suppress the inﬂam-
matory process.5 This downregulation is more effective in sup-
pressing asthma and allergy in ‘developing’ countries where
hygiene is poor and there is a greater probability of being exposed
to infectious microbes than in ‘developed’ countries.6
Epidemiological studies have examined whether helminthic
infections increase or decrease the prevalence of asthma and al-
lergy, but the results have been controversial. However, it seems
likely that infection byAscaris increases the prevalence ofwheezing.
Treatment of Ascaris infection has been shown to decrease the
severity of asthma in Venezuela.7 A systematic review and meta-
analysis of 22 studies calculated the odds ratio (OR) of Ascaris
infection for wheezing to be 1.34.8 A study undertaken in China of
bronchial hyper-responsiveness (BHR), which is a more speciﬁc
indicator of asthma symptoms than simple recurrent wheezing,
showed that Ascaris infection increased the prevalence of BHR.9 It
has been suggested that non-atopic asthma is associated with
Ascaris infections in children living in poor neighborhoods in
Brazil.10 Furthermore, anti-Ascaris immunoglobulin (Ig)E seems to
contribute to the development of wheezing. High levels of anti-
Ascaris IgE have been found to be associated with an increased risk
of asthma in a cohort study from the former East Germany where
exposure to Ascaris was low.11 A study of a population in South
Africa exposed to mild infection by Ascaris suggested that anti-
Ascaris IgEwas a risk factor for atopic diseases.12 Anti-Ascaris IgE has
been shown to increase the risk of BHR in Costa Rica.13 In addition to
the observation that anti-Ascaris IgE increases the risk of wheezing
in low endemic areas, we demonstrated that elevated levels of anti-
Ascaris IgE were associated with wheezing in children in rural
Bangladesh, where the prevalence of Ascaris infection reached
75%.14 Anti-Ascaris IgE was shown to be a risk factor for wheezing
and/or atopy in preschool-aged Brazilian children.15 The ﬁndings
mentioned above suggest that anti-Ascaris IgE is associated with an
increased risk of wheezing regardless of exposure levels to Ascaris.
However, our former study was based on a questionnaire rather
than on direct measurements of BHR. In the present study, we
included BHR testing to ascertain if anti-Ascaris IgE levels are
associated with BHR in high endemic areas. This strategy enabled
us to dissect the results of the 2001 study.
Methods
Ethics, consent and permissions
The study protocol the Addendumof the protocol #2000-038was
approved by the Ethical Review Committee of the International
Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). This
study involves human subjects and it meets the ethical principles of
the Declaration of Helsinki. We also obtained written informed con-
sent from the guardians of the childrenwho participated in the study.Study site and participants
The study population was from Matlab, a riverine rural area
located 45 km southeast of Dhaka, the capital of Bangladesh, as
described previously.14,16 We had identiﬁed 219 children who had
experienced wheezing during the previous 12 months (‘current
wheezers’), and randomly selected 122 controls who had never
wheezed (‘never-wheezers’) using a questionnaire from the Inter-
national Study of Asthma and Allergies in Childhood (ISAAC) in the
study conducted in 2001.We administered this questionnaire again
to these children in 2005. We found that 114 children out of the 194
former current wheezers whose guardians provided written
informed consent reported ‘current wheezing’. For comparison, we
randomly selected 82 never-wheezers from the 122 never-
wheezers, and 69 responded to the questionnaire after their
guardians provided written informed consent. Out of these chil-
dren, we found 44 never-wheezers in 2005 (Fig. 1). We undertook a
BHR test on these children in 2005. There were several reasons for
non-participation: ﬁve children left the area; 20 refused to partic-
ipate; ﬁve were absent at the time of the visit; eight were too ill to
participate.Data collection
Collection of data and samples was undertaken from March to
July 2005. Childrenwere referred to Matlab Hospital if they agreed
to participate in the study. At the hospital, study physicians took a
medical history and ascertained the physical status of the chil-
dren, and carried out a BHR test after obtaining written informed
consent from their guardians. Data from the ISAAC questionnaire
and data on other socio-environmental factors were obtained.17
Serum samples were separated within 3 h of blood collection
and stored at 20 C. Total level of IgE in serum was measured
using the ﬂuoro enzyme immunoassay (FEIA) method (Pharmacia
KK, Tokyo, Japan). IgE antibodies speciﬁc to Dermatophagoides
pteronyssinus (DP) and Ascaris lumbricoideswere measured by the
CAP-FEIA system (Pharmacia KK). Fresh stool specimens were
examined for parasites using a direct smear method without
concentration.14BHR testing
A bronchial challenge test that complied with the ISAAC
protocol with some modiﬁcations was carried out.18e20 Microsoft
Windows™-based spirometer software (Spiro 2000) was used to
measure the forced vital capacity (FVC) and forced expiratory
volume in one second (FEV1). Hypertonic saline (4.5%) was used
for challenge with an ultrasonic nebuliser (U17; Omron Health-
care, Kyoto, Japan). This nebuliser could produce an output of
1.5 ml/min and generate an aerosol with a mass median
diameter of 2e5 mm. Salbutamol, cromoglycate, theophylline and
anti-histamine agents were withheld before the airway-
challenge test according to the protocol. In accordance with the
ISAAC protocol, provocation tests were not carried out on chil-
dren with a FEV1 <75% of the predicted value. In such cases a
bronchodilator was administered and repeated spirometry done
10-min later.
The exposure time for inhaling 4.5% hypertonic saline was
increased progressively from an initial exposure time of 30 s to 1, 2,
4 and 8min. FEV1 was measured after each exposure. The challenge
was stopped if the fall in FEV1 was 15% or after a maximum
inhalation period of 15.5 min. A positive BHR test was deﬁned as a
fall by 15% of the baseline value in FEV1, or FEV1 of <75% of the
predicted value with recovery by bronchodilators.
Fig. 1. Flowchart of the sampling procedure. In the study conducted in 2001, villagers were collected randomly from all 67 villages in the DSS intervention area until the total
number of included children of the targeted age exceeded 1700 (the calculated sample size). Finally, 1705 children were selected from 51 of the villages and 1580 children
participated in the study with written informed consent. Finally, participants comprised 219 ‘current wheezers’ and 122 ‘never-wheezers’. In the 2005 study, we approached all the
wheezing children and randomly selected 82 never-wheezing children, who at that time were 9 years of age. Of the 219 wheezing children, 194 agreed to participate, and 69 of the
82 never-wheezing children agreed. We found 114 current-wheezing children in the 194 former-wheezing participants and 44 never-wheezing children in the 69 former never-
wheezing participants. We undertook lung function tests on these 158 children. Out of the 114 current-wheezing children, 59 showed a BHR-positive test and 32 were BHR-negative
out of the 44 never-wheezing children. Analyses were done ﬁrst between the 114 current wheezing children and 44 never-wheezing children, and then between the 59 BHR-
positive children and 32 BHR-negative children.
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Sample size was calculated according to the mean and standard
deviation (SD) values of loge-transformed anti-Ascaris IgE values
among current wheezers and never-wheezers, which were 2.78 UA/
ml (SD, 1.37) and 2.07 UA/ml (SD, 1.52), respectively.14 To determine
the difference between BHR-positive and BHR-negative groups
with 80% power at a signiﬁcance level of 5%, we estimated that we
required a sample size of 21 subjects per group. To obtain this
number of BHR-positive subjects, we tested 42 children in each
wheezing group because the sensitivity of the challenge test using
4.5% saline was 30e50%.
Data were analysed using SPSS v22 (IBM Japan, Tokyo, Japan).
Analyses were undertaken ﬁrst between the consistently wheezing
group (n ¼ 114) and the consistently never-wheezing group
(n¼ 44). Then, analyses were carried out between the BHR-positive
children in the current wheezers (n ¼ 59) and the BHR-negative
children from the never-wheezers (n ¼ 32). After each variable
had undergone descriptive analyses, crude ORs and adjusted ORs of
IgE values for consistently current wheezers and BHR results were
calculated using logistic regression models. Odds ratio (OR) of anti-
Ascaris IgE was adjusted for sex, pneumonia, parental asthma, Tri-
churis infection, eosinophils, total IgE, anti-DP IgE and FEV1. OR of
total IgE was adjusted for sex, pneumonia, parental asthma, Tri-
churis infection, eosinophils, anti-Ascaris IgE, anti-DP IgE and FEV1.
OR of anti-DP IgE was adjusted for sex, pneumonia, parental
asthma, Trichuris infection, eosinophils, anti-Ascaris IgE, total IgE
and FEV1. OR of FEV1 was adjusted for sex, pneumonia, parental
asthma, Trichuris infection, eosinophils, anti-Ascaris IgE, total IgE
and anti-DP IgE. Although in the previous study in the year 2001
there was a weak tendency that children with short stature and
lower weight and from lower income household were more likely
to wheeze, the result was not always consistent. Thus, we did not
include these variables as co-variates.There were 10 children who were non-wheezers in 2001 but
current wheezers in 2005, and 9 children who were current
wheezers in 2001 but non-wheezers in 2005. We compared the
anti-Ascaris IgE and anti-DP IgE levels and the prevalence of BHR
positive rates between these 2 groups.
Results
Among the selected 301 children, 263 (87%) children agreed to
participate in the study (Fig. 1). We found 114 children who re-
ported current wheezing again in 2005 from the 194 current
wheezing children in 2001 and 44 never-wheezing children from
the 69 never-wheezing children in 2001. The BHR test was carried
out on these children. Among 158 BHR-tested participants, 152
children were challenged successfully. Out of 114 wheezing chil-
dren, 59 (55%) were BHR-positive, and 32 (73%) were BHR-negative
out of 44 never-wheezing children.
Then, we ﬁrst compared the characteristics of participants be-
tween the 114 wheezing group and 44 never-wheezing group, and
second between the 59 BHR-positive with wheezing and the 32
BHR-negative without wheezing groups. Table 1 shows the vari-
ables of the study population of which the differences were proved
to be signiﬁcant by bivariate analysis or variables that were thought
to be relevant. Signiﬁcant differences between the two groups were
found in the variables of: history of pneumonia; parental asthma;
FVC; FEV1.
Table 2 shows the serum levels of total IgE, anti-Ascaris IgE, and
anti-DP IgE by the severity of asthma symptoms as expressed by the
presence of: sleep disturbance; 4 attacks per year; speech difﬁ-
culty. Anti-Ascaris IgE level was high in those groups as well as in
the consistently wheezing group and BHR-positive group, as we
reported previously.14
Finally, we calculated the crude OR and adjusted OR values of
total and speciﬁc IgE values for wheezing and positive-BHR tests in
Table 1
Description of the characteristics of the population and the ORs of the variables used for adjustment for presence of wheezing and BHR.
Wheezers Never-wheezers Crude OR P BHR positive BHR-negative Crude OR P
n ¼ 114 n ¼ 44 n ¼ 59 n ¼ 32
Male/female 58/56 (51%) 23/21 (52%) 1.06 (0.53e2.12) 0.875 31/28 (52%) 14/18 (44%) 1.42 (0.60e3.38) 0.424
Helminth infection (n)y (109) (42) (57) (31)
Ascaris Yes 83 (76%) 29 (63%) 1.43 (0.65e3.15) 0.373 48 (84%) 24 (77%) 1.56 (0.52e4.69) 0.432
Trichuris Yes 54 (50%) 27 (64%) 0.54 (0.26e1.14) 0.106 27 (47%) 21 (68%) 0.43 (0.17e1.07) 0.070
History of pneumonia
During 5 years Yes 54 (47%) 5 (11%) 7.02 (2.58e19.10) 0.001 30 (51%) 4 (13%) 7.24 (2.26e23.22) 0.001
Total eosinophils count (%)z 11.5 (10.3e12.7) 9.6 (7.7e11.6) 1.05 (0.99e1.12) 0.102 12 (10.8e14.2) 9.5 (7.3e11.6) 1.09 (1.01e1.17) 0.037
Asthmatic parents Yes/no 44/70 (39%) 5/39 (11%) 7.68 (1.79e33.0) 0.006 38 (64%) 4 (13%) 3.87 (1.19e12.53) 0.024
FVCz ml Mean
(95% CI)
1139 (1092e1185) 1240 (1171e1308) 0.99 (0.99e1.00) 0.025 1107 (1052e1115) 1252 (1165e1339) 0.99 (0.994e0.999) 0.008
FEV1z 1127 (1109e1192) 1203 (1135e1271) 0.99 (0.99e1.00) 0.037 1083 (1028e1137) 1232 (1125e1311) 0.99 (0.993e0.999) 0.002
OR, odds ratio; BHR, bronchial hyper-responsiveness; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; CI, conﬁdence interval.
y The numbers in the brackets indicate those who tested for helminth infection. Not all participants were tested.
z The unit of change in the calculation of OR is 1.
Table 2
Geometric mean levels of total and speciﬁc IgE.
n Total IgE Anti-Ascaris IgE Anti-DP IgE
Geometric mean (95% CI) (IU/ml) Geometric mean (95% CI) (UA/ml) Geometric mean (95% CI) (UA/ml)
Never-wheezers with BHR () 32 1579 (1051e2372) 3.89 (2.65e5.70) 1.40 (1.09e1.80)
Never-wheezers 44 1744 (1255e2426) 4.59 (3.27e6.45) 1.42 (1.12e1.80)
Current wheezers 114 2392 (1899e3014) 9.12 (7.02e11.84) 1.60 (1.36e1.89)
Sleep disturbance 93 2119 (1650e2722) 7.94 (5.96e10.57) 1.55 (1.30e1.85)
4 attacks 31 2729 (1767e4219) 11.52 (7.13e18.63) 1.31 (1.06e1.63)
Speech difﬁculty 13 3293 (1927e5628) 13.26 (6.57e26.75) 1.50 (0.90e2.50)
BHR-positive 59 2912 (2224e3813) 12.51 (9.21e17.00) 1.92 (1.50e2.47)
IgE, immunoglobulin E; CI, conﬁdence interval; DP, Dermatophagoides pteronyssinus; BHR, bronchial hyper-responsiveness.
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Anti-Ascaris IgE level proved to be associated with wheezing and a
BHR-positive test in all severity groups. History of pneumonia and
parental asthmawere signiﬁcantly and increasingly associatedwith
wheezing and positive-BHR tests, and FEV1 was inversely associ-
ated with wheezing and BHR.
Last when we compared the anti-Ascaris IgE and anti-DP IgE
levels and the prevalence of BHR positive rates between the 2
groups of 10 children who were non-wheezers in 2001 but current
wheezers in 2005, and of the 9 children who were current
wheezers in 2001 but non-wheezers in 2005, we found no statis-
tical difference between the 2 groups probably because of the small
sample size.
Discussion
We showed that anti-Ascaris IgE levels were associated with an
increased risk of a BHR-positive test in 9-year-old children in rural
Bangladesh, where the prevalence of Ascaris infection was 75%.14
Simultaneously, a signiﬁcantly higher proportion of wheezing
children in 2001 and 2005 (consistently wheezing children), who
were highly likely to be suffering from BA, showed a signiﬁcantly
higher number of positive tests for BHR than childrenwhowere not
suffering from wheezing in 2001 and 2005, and anti-Ascaris IgE
levels were associated with an increased risk of consistent
wheezing.
In Matlab helminths infections have been dramatically reduced
since national mass chemotherapy strategy started around 2004.
However, the participants of this study did not receive that beneﬁt
and almost 70% of both of the wheezing and non-wheezing chil-
drenwere infected with Ascaris (data not shown) at that time. Even
though the prevalence became low in the younger generation in
2005, it does not necessarily mean that the prevalence in the older
generation was low. There might be difference in the effect ofAscaris infection on wheezing between dewormed and non-
dewormed groups. Recently deworming is done for children
twice a year. However, it was found that soil-transmitted helminth
especially Ascaris lumbricoides infections recur rapidly after treat-
ment.21 We are not sure about the difference in the extent of
wheezing at the time of larval migration of Ascaris between re-
infection and the additional infection when deworming is not
done. We have to examine about this in the future.
In this study, anti-Ascaris IgE was associated with wheezing, but
no association was observed between current infection and
wheezing, suggesting that IgE reactivity, not infection itself, against
Ascaris is related towheezing. These ﬁndings are in agreement with
those of our former study, which showed an increasing association
between anti-Ascaris IgE levels and wheezing. The present study
enabled us to conﬁrm the results that were obtained during 2001
study (which used questionnaires rather than the BHR test).
Despite reported inverse associations of helminthic infections
and asthma-like symptoms in various studies, Ascaris seems to be
positively associated with asthma-like symptoms.7e15 In addition,
Hagel et al. reported that anti-Ascaris IgE level is associated with an
increased risk of BHR and decreased FEV1 in areas where Ascaris is
highly prevalent.22 The study by Hagel et al.was the ﬁrst to showan
association between anti-Ascaris IgE level and BHR in highly
endemic areas, but it did not take other confounding factors into
consideration. Associations between BHR and anti-Ascaris IgE level
in low-prevalence areas have also been reported.9,13 In accordance
with those studies, we found a signiﬁcant association between anti-
Ascaris IgE level and BHR among children with high infectious
burden.
Helminthic infections have been associated with negative skin
prick tests to aeroantigens.23 In general, helminthic infections
induce a Th2 immune response characterised by production of IL-4,
IL-5 and IL-13 by Th2 cells, elevated levels of IgE, tissue eosino-
philia, and mastcytosis for protection of the host and,
Table 3
Odds ratios for current wheezing and BHR relative to the total, anti-Ascaris and anti-DP IgE including if children with less speciﬁc asthma symptoms are excluded.
Wheezers/non-wheezers Units of change Crude odds ratio (95% CI) p Adjusted odds ratio (95% CI) p
Anti-Ascaris IgE (loge transformed) y
Current wheezing 114/44 1 1.46 (1.10e1.93) 0.008 2.31 (1.24e4.32) 0.009
Attack 4 timesyy 31/41 1 1.87 (1.24e2.83) 0.003 1.37 (1.18e1.96) 0.014
Sleep disturbancezz 93/41 1 1.38 (1.04e1.83) 0.024 2.02 (1.07e3.82) 0.031
Speech disturbancexx 14/43 1 2.18 (1.20e4.00) 0.011 4.10 (1.00e16.71) 0.049
BHR¶¶ 59/32 1 2.37 (1.54e3.63) <0.001 7.30 (2.28e23.33) 0.001
Total IgE (loge transformed) z
Current wheezing 114/44 1 1.23 (0.91e1.65) 0.178 0.56 (0.29e1.08) 0.082
Attack 4 timesyy 31/41 1 1.47 (0.96e2.26) 0.079 0.41 (0.10e1.65) 0.207
Sleep disturbancezz 93/41 1 1.18 (0.88e1.59) 0.279 0.58 (0.29e1.15) 0.121
Speech disturbancexx 14/43 1 1.69 (1.30e2.19) <0.001 1.09 (0.31e3.88) 0.898
BHR¶¶ 59/32 1 1.69 (1.12e2.57) 0.013 0.33 (0.11e1.01) 0.052
Anti-DP IgE (loge transformed) x
Current wheezing 114/44 1 1.75 (0.87e3.50) 0.115 0.88 (0.50e1.56) 0.668
Attack 4 timesyy 31/41 1 0.96 (0.50e1.86) 0.905 0.08 (0.01e0.69) 0.022
Sleep disturbancezz 93/41 1 1.19 (0.74e1.90) 0.477 0.89 (0.50e1.60) 0.693
Speech disturbancexx 14/43 1 1.21 (0.99e1.48) 0.062 0.49 (0.17e1.43) 0.191
BHR¶¶ 59/32 1 1.67 (0.93e3.01) 0.089 1.38 (0.66e2.88) 0.394
FEV1 ¶
Current wheezing 114/44 1 0.998 (0.996e1.00) 0.017 0.99 (0.99e1.00) 0.194
Attack 4 timesyy 31/41 1 0.998 (0.995e1.00) 0.037 1.03 (0.998e1.05) 0.068
Sleep disturbancezz 93/41 1 0.998 (0.997e1.00) 0.048 1.00 (0.998e1.01) 0.179
Speech disturbancexx 14/43 1 1.11 (0.91e1.36) 0.291 0.997 (0.992e1.001) 0.167
BHR¶¶ 59/32 1 0.996 (0.99e1.00) 0.001 0.995 (0.990e0.999) 0.015
CI, conﬁdence interval; BHR, bronchial hyper-responsiveness; FEV1, forced expiratory volume in one second; DP, Dermatophagoides pteronyssinus.
y Odds ratio (OR) of anti-Ascaris IgE was adjusted for sex, pneumonia, parental asthma, Trichuris infection, eosinophils, total IgE, anti-DP IgE and FEV1.
z OR of total IgE was adjusted for sex, pneumonia, parental asthma, Trichuris infection, eosinophils, anti-Ascaris IgE, anti-DP IgE and FEV1.
x OR of anti-DP IgE was adjusted for sex, pneumonia, parental asthma, Trichuris infection, eosinophils, anti-Ascaris IgE, total IgE and FEV1.
¶ OR of FEV1 was adjusted for sex, pneumonia, parental asthma, Trichuris infection, eosinophils, anti-Ascaris IgE, total IgE and anti-DP IgE.
yy Individuals who had experienced fewer than four attacks of wheezing during the previous year were excluded from the analyses.
zz Those whose sleep had not been disturbed during the previous year were excluded from the analyses.
xx Those whose speech had not been disturbed by wheezing during the previous year were excluded from the analyses.
¶¶ Dependent variable was BHR-positive or not.
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kines such as IL-10 and TGF-beta.24e26 This concept has been
studied comprehensively in ﬁlariasis.27,28 Treg-type immunity is
considered to play a crucial part in suppressing asthma symptoms
in developing countries, where the infectious burden because of
helminths is considerable.5,6,29
Despite these observations suggesting that helminths suppress
allergy, anti-Ascaris IgE seems to contribute to the enhancement of
asthma-like symptoms.11e15 However, the role of anti-Ascaris IgE in
asthma symptoms is not obvious, and may be fourfold.
First, anti-Ascaris IgE may act like an antibody to inhalant anti-
gens to trigger degranulation of mast cells to induce Th2 inﬂam-
mation on re-exposure to inhalant Ascaris antigen. Second, the
elevated anti-Ascaris IgE level might only be coincident with larval
migration after infection. Ascaris nematodes migrate through the
lungs during maturation, and cause Th2-type pulmonary inﬂam-
mation and episodic wheezing. In such a situation, anti-Ascaris IgE
productionwould be boosted by re-exposure to Ascaris antigen. We
might merely be observing coincident enhanced production of
anti-Ascaris IgE and asthma-like symptoms, which is well known as
‘tropical pulmonary eosinophilia’. Third, although we speculate
that anti-Ascaris IgE causes wheezing/BHR, the higher anti-Ascaris
IgE levels observed in the wheezing/BHR group might be because
atopic children produce more anti-Ascaris IgE in response to stim-
ulation by Ascaris.13 In the present study, however, the anti-Ascaris
IgE level retained its signiﬁcance after adjustment for anti-DP IgE,
suggesting that it is an independent risk factor for wheezing/BHR.14
Fourth, although various reports have attributed involvement of
anti-Ascaris IgE to cross-reactivity with IgE from mites or cock-
roaches, the magnitude of these IgE antibodies bore no comparison
with that of anti-Ascaris IgE in our previous and present study.14
Thus, we speculate the presence of a different mechanism in theeffect of anti-Ascaris IgE on the development of wheezing/BHR
other than cross-reactivity with the IgE of mites or cockroaches.
Other risk factors for a BHR-positive test were found to be a
history of pneumonia, total IgE, parental asthma, and FEV1. A his-
tory of pneumonia has remained a risk factor consistently
throughout our studies. This observation is in agreement with the
consensus regarding development of recurrent wheezing in chil-
dren worldwide. FVC and FEV1 had inverse associations with
wheezing and BHR (Table 1). However, we omitted FVC from the
analyses because of multi-collinearity: the variance inﬂation factor
was >10. Although we measured FEV1/FVC, it had no association
with wheezing or a BHR-positive test (data not shown). This result
may have been because of our lack of technical skill for measuring
FVC, or insufﬁcient expiration at the time of measurement. In our
previous study in 2001 there was aweak association between short
stature and low weight. A study from Matlab also reported the
association of wheezing, although this study did not take respira-
tory tract infections, the strongest risk factor for wheezing, into
consideration on.30
Our study did not indicate any contribution of Ascaris infection
to wheezing nor BHR positivity. However, the effect of the severity
of Ascaris infection (asmeasured by egg counts) to the development
of asthma symptoms has been reported from the same rural area of
Bangladesh (Matlab) recently.31 Studies from Matlab (including
ours) imply that Ascaris infection per se or its products may have a
role on the development of asthma in this area. Studies on the
ability to induce a Treg response to various types of helminth
(including Ascaris) will be required to establish their contribution
on the suppression or exacerbation of asthma and allergy.32
The risk factors from our studies for wheezing and BHR when
Ascaris infection is prevalent, are anti-Ascaris IgE, history of pneu-
monia and parental asthma in rural Bangladesh. Trichuris might be
H. Takeuchi et al. / Allergology International 65 (2016) 141e146146a decreasing risk factor. When people use dry leaves for their
cooking fuel, it becomes an increasing risk factor. Smoke from fuel
was a risk factor because children stay with their mothers while
they cook and severely were exposed. On the other hand, tobacco
smoking was not a risk factor. It was probably because people
smoke outside of their homes in a rural situation which does not
cause passive smoking to the children.
To conclude, anti-Ascaris IgE plays an important role in the
development of wheezing and BHR positive test among rural
Bangladeshi children. Studies on the ability to induce a Treg
response to various types of helminth (including Ascaris) will be
required to establish their contribution on the suppression or
exacerbation of asthma and allergy.
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